Loading insider details...
Beta
Latest Form 4 (Jul 29, 2026): Grant/Award of 11,883 PCSA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 29, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/Award | 11,883 | n/a |
| Jul 1, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 3,277 | $6.3K |
| Jun 16, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 2,654 | $5.9K |
| Jun 1, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 2,292 | $5.9K |
| May 19, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 1,984 | $5.9K |
| May 1, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 2,190 | $5.9K |
| Apr 17, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 1,984 | $5.9K |
| Apr 1, 2026 | Processa Pharmaceuticals, Inc. (PCSA) | Purchase | 2,324 | $5.9K |
| Oct 3, 2025 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/Award | 108,000 | n/a |
| Jul 28, 2025 | Processa Pharmaceuticals, Inc. (PCSA) | Grant/Award | 1,775,044 | n/a |